The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-08-31

Study Completion Date

2030-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease

NCT04620980

Parkinson Disease

UNKNOWN

Parkinson's Disease Genetics Database

NCT00855556

Parkinson's Disease

TERMINATED

Parkinson's Foundation PD GENEration Genetic Registry

NCT04994015

Parkinson's Disease

RECRUITING

Neurogenetics Patient Registry

NCT02995538

Neurogenetic Disorders

RECRUITING

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

NCT01536821

Parkinson Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Treatment

There is no intervention, this is a biorepository.

Intervention Type OTHER

There are no interventions in this study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

There is no intervention, this is a biorepository.

There are no interventions in this study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Is age 30 years or older at the time of onset of Parkinson's
* Has been diagnosed with idiopathic Parkinson's Disease by a Scripps Neurologist
* Is reliable, cooperative and willing to comply with all protocol-specified procedures and/or sub-study if consented or have legal representative/guardian willing to do so
* Able to understand and grant informed consent or have a legal representative/ guardian who is able to do so

Exclusion Criteria

* Patient has been previously enrolled in The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry
* If a blood draw would be contraindicated for any reason
* Has a significant chronic medical condition (i.e. CVA, hepatic encephalopathy) which, in the investigator's option, may interfere with the patient's optimal participation in the study
* Treatment with any investigational agents or devices within 30 days preceding enrollment in the study
* Has undergone ECT within 90 days preceding enrollment in the study

Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No